Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Res ; 64: 72-81, 2019 04.
Article in English | MEDLINE | ID: mdl-30802725

ABSTRACT

Regular consumption of low- and nonfat dairy products reduces blood pressure (BP) in adults with elevated BP. Currently, it is unknown if conventional full-fat dairy products exert similar hypotensive effects. We hypothesized that adding full-fat dairy products to the normal routine diet would reduce seated office and ambulatory BP (primary outcome) in adults with elevated BP when compared with a no dairy control. Using a randomized controlled crossover design, 60 adults with elevated systolic BP (systolic/diastolic BP: 120-159/<99 mm Hg) participated in a 4-week high-dairy (4 servings a day of full-fat dairy products + regular diet) and a 4-week no-dairy condition (plant-based food items + regular diet) separated by a 2-week washout period. Data were analyzed based on time, condition, and sex. Seated office systolic BP did not change significantly in either condition. There were no changes in systolic BP in male or female participants across either dietary period. Ambulatory (24-hour) systolic BP did not change significantly in the high-dairy (133 ±â€¯2 vs 131 ±â€¯1 mm Hg) or no-dairy conditions (132 ±â€¯2 vs 131 ±â€¯1 mm Hg). No significant changes were observed for diastolic BP or pulse pressure during condition for office or ambulatory measures. The solitary addition of full-fat dairy products to the normal routine diet does not exert hypotensive effects in adults with elevated BP when compared to the no-dairy control.


Subject(s)
Blood Pressure , Diet , Dietary Fats/pharmacology , Feeding Behavior , Hypertension , Milk/chemistry , Adult , Aged , Animals , Dairy Products/analysis , Female , Humans , Hypertension/diet therapy , Male , Middle Aged , Young Adult
2.
J Quant Spectrosc Radiat Transf ; 186: 17-39, 2017 Jan.
Article in English | MEDLINE | ID: mdl-32817995

ABSTRACT

TEMPO was selected in 2012 by NASA as the first Earth Venture Instrument, for launch between 2018 and 2021. It will measure atmospheric pollution for greater North America from space using ultraviolet and visible spectroscopy. TEMPO observes from Mexico City, Cuba, and the Bahamas to the Canadian oil sands, and from the Atlantic to the Pacific, hourly and at high spatial resolution (~2.1 km N/S×4.4 km E/W at 36.5°N, 100°W). TEMPO provides a tropospheric measurement suite that includes the key elements of tropospheric air pollution chemistry, as well as contributing to carbon cycle knowledge. Measurements are made hourly from geostationary (GEO) orbit, to capture the high variability present in the diurnal cycle of emissions and chemistry that are unobservable from current low-Earth orbit (LEO) satellites that measure once per day. The small product spatial footprint resolves pollution sources at sub-urban scale. Together, this temporal and spatial resolution improves emission inventories, monitors population exposure, and enables effective emission-control strategies. TEMPO takes advantage of a commercial GEO host spacecraft to provide a modest cost mission that measures the spectra required to retrieve ozone (O3), nitrogen dioxide (NO2), sulfur dioxide (SO2), formaldehyde (H2CO), glyoxal (C2H2O2), bromine monoxide (BrO), IO (iodine monoxide),water vapor, aerosols, cloud parameters, ultraviolet radiation, and foliage properties. TEMPO thus measures the major elements, directly or by proxy, in the tropospheric O3 chemistry cycle. Multi-spectral observations provide sensitivity to O3 in the lowermost troposphere, substantially reducing uncertainty in air quality predictions. TEMPO quantifies and tracks the evolution of aerosol loading. It provides these near-real-time air quality products that will be made publicly available. TEMPO will launch at a prime time to be the North American component of the global geostationary constellation of pollution monitoring together with the European Sentinel-4 (S4) and Korean Geostationary Environment Monitoring Spectrometer (GEMS) instruments.

3.
J Leukoc Biol ; 66(1): 113-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10410998

ABSTRACT

The transport of iron by RAW264.7 macrophage cell lines transfected with either Nramp1Gly169 (resistant) or Nramp1ASp169 (susceptible) alleles was assessed. We found no difference between resistant and susceptible cells in the rate of Fe import or export when Fe transport was measured in intact cells. In contrast, the rate of Fe import by latex-bead phagosomes isolated from resistant cells was more than double the rate by latex-bead phagosomes from susceptible cells. Similarly, phagosomes isolated from resistant cells that had been pre-labeled with 55Fe-citrate before phagocytosis contained up to four times as much Fe as the corresponding phagosomes from susceptible cells. Phagocytosis of Mycobacterium avium was accompanied by an increase in the production of hydroxyl radicals by Nramp1cGly169-transfected macrophages but not by macrophages transfected with the susceptible allele. These results are consistent with the hypothesis that Nramp1 functions to transport Fe into the bacterium-containing phagosome where it serves as a catalyst for the Haber-Weiss reaction, which accounts for the increased capacity of these cells to limit mycobacterial growth.


Subject(s)
Aspartic Acid/metabolism , Carrier Proteins/metabolism , Cation Transport Proteins , Glycine/metabolism , Iron/metabolism , Macrophages/metabolism , Membrane Proteins/metabolism , Phagosomes/metabolism , Animals , Aspartic Acid/genetics , Biological Transport , Blotting, Western , Carrier Proteins/genetics , Cations , Cell Line , Glycine/genetics , Hydroxyl Radical/metabolism , Macrophages/cytology , Male , Membrane Proteins/genetics , Metals , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Microspheres , Subcellular Fractions , Transfection
4.
FEMS Microbiol Lett ; 131(2): 121-6, 1995 Sep 01.
Article in English | MEDLINE | ID: mdl-7557319

ABSTRACT

A promoter probe shuttle vector suitable for the isolation of promoter elements from coryneform bacteria was constructed. This vector carried the neomycin phosphotransferase (NPTII) gene from transposon Tn5 as a reporter gene, and was capable of replication in both Escherichia coli and Brevibacterium flavum. The vector was used in the construction of a B. flavum library of 899 independently isolated promoter clones. Promoters with a wide range of activities in B. flavum, including some very strong promoter elements, were isolated. Comparative analysis suggests that significant differences between B. flavum and E. coli may exist in the determinants of promoter strength.


Subject(s)
Brevibacterium/genetics , Escherichia coli/genetics , Promoter Regions, Genetic , Base Sequence , Biotechnology , DNA, Recombinant/genetics , Escherichia coli/drug effects , Gene Expression Regulation, Bacterial , Genes, Reporter , Genetic Engineering , Genetic Vectors , Kanamycin Resistance/genetics , Molecular Sequence Data , Transformation, Genetic
5.
Transplantation ; 52(6): 1029-36, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1836284

ABSTRACT

The immunopathological appearances of skin and rectum in 64 autologous and allogeneic recipients were determined before and after bone marrow transplantation. Patients who developed acute graft-versus-host disease were biopsied as soon as a clinical diagnosis was made. At the same time peripheral blood samples were collected for comparative analysis. Immunohistological and morphometric techniques were employed using a panel of monoclonal antibodies to T lymphocytes and subsets, B lymphocytes, natural killer cells, macrophages, and Langerhans cells. A reduction in the CD4/CD8 ratio after BMT was seen in skin and rectal biopsies from both autologous and allogeneic recipients with or without GVHD. The same pattern was observed in blood samples taken at the same time. Langerhans cells were reduced in the skin in all patients after BMT, probably by the conditioning regimen. Only a few cells expressing activation or natural killer cell markers were present and there were no changes observed in the macrophage population. This study has provided no evidence to implicate either CD4- or CD8-positive T lymphocytes as the initiators of the cellular damage in acute GVHD. The distribution of lymphocyte subsets in the blood was similar to that in the tissues, suggesting that the tissue changes reflect the pattern of lymphocyte repopulation after BMT and may have little bearing on the pathogenesis of GVHD.


Subject(s)
Bone Marrow Transplantation/adverse effects , Graft vs Host Disease/pathology , Adolescent , Adult , Antigens, Differentiation, T-Lymphocyte/analysis , Biopsy , CD3 Complex , CD4-CD8 Ratio , CD8 Antigens/analysis , Child , Child, Preschool , Graft vs Host Disease/blood , Graft vs Host Disease/etiology , Humans , Leukocyte Count , Middle Aged , Prospective Studies , Receptors, Antigen, T-Cell/analysis , Rectum/pathology , Skin/pathology , T-Lymphocytes/cytology , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...